Anastasia Wyce
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anastasia Wyce.
Molecular and Cellular Biology | 2001
Westley J. Friesen; Sergey Paushkin; Anastasia Wyce; Séverine Massenet; G. Scott Pesiridis; Gregory D. Van Duyne; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
ABSTRACT snRNPs, integral components of the pre-mRNA splicing machinery, consist of seven Sm proteins which assemble in the cytoplasm as a ring structure on the snRNAs U1, U2, U4, and U5. The survival motor neuron (SMN) protein, the spinal muscular atrophy disease gene product, is crucial for snRNP core particle assembly in vivo. SMN binds preferentially and directly to the symmetrical dimethylarginine (sDMA)-modified arginine- and glycine-rich (RG-rich) domains of SmD1 and SmD3. We found that the unmodified, but not the sDMA-modified, RG domains of SmD1 and SmD3 associate with a 20S methyltransferase complex, termed the methylosome, that contains the methyltransferase JBP1 and a JBP1-interacting protein, pICln. JBP1 binds SmD1 and SmD3 via their RG domains, while pICln binds the Sm domains. JBP1 produces sDMAs in the RG domain-containing Sm proteins. We further demonstrate the existence of a 6S complex that contains pICln, SmD1, and SmD3 but not JBP1. SmD3 from the methylosome, but not that from the 6S complex, can be transferred to the SMN complex in vitro. Together with previous results, these data indicate that methylation of Sm proteins by the methylosome directs Sm proteins to the SMN complex for assembly into snRNP core particles and suggest that the methylosome can regulate snRNP assembly.
Molecular Cell | 2001
Westley J. Friesen; Séverine Massenet; Sergey Paushkin; Anastasia Wyce; Gideon Dreyfuss
The survival of motor neurons protein (SMN), the product of the neurodegenerative disease spinal muscular atrophy (SMA) gene, functions as an assembly factor for snRNPs and likely other RNPs. SMN binds the arginine- and glycine-rich (RG) domains of the snRNP proteins SmD1 and SmD3. Specific arginines in these domains are modified to dimethylarginines, a common modification of unknown function. We show that SMN binds preferentially to the dimethylarginine-modified RG domains of SmD1 and SmD3. The binding of other SMN-interacting proteins is also strongly enhanced by methylation. Thus, methylation of arginines is a novel mechanism to promote specific protein-protein interactions and appears to be key to generating high-affinity SMN substrates. It is reasonable to expect that protein hypomethylation may contribute to the severity of SMA.
Molecular Cell | 2008
Xiao-yong Zhang; Maya Varthi; Stephen M. Sykes; Charles Phillips; Claude C. Warzecha; Wenting Zhu; Anastasia Wyce; Alan W. Thorne; Shelley L. Berger; Steven B. McMahon
Polycomb genes encode critical regulators of both normal stem cells and cancer stem cells. A gene signature that includes Polycomb genes and additional genes coregulated with Polycomb genes was recently identified. The expression of this signature has been reported to identify tumors with the cancer stem cell phenotypes of aggressive growth, metastasis, and therapy resistance. Most members of this 11 gene signature encode proteins with well-defined roles in human cancer. However, the function of the signature member USP22 remains unknown. We report that USP22 is a previously uncharacterized subunit of the human SAGA transcriptional cofactor complex. Within SAGA, USP22 deubiquitylates histone H2B. Furthermore, USP22 is recruited to specific genes by activators such as the Myc oncoprotein, where it is required for transcription. In support of a functional role within the Polycomb/cancer stem cell signature, USP22 is required for appropriate progression through the cell cycle.
Molecular and Cellular Biology | 2005
Kristin Ingvarsdottir; Nevan J. Krogan; N. C. Tolga Emre; Anastasia Wyce; Natalie J. Thompson; Andrew Emili; Timothy Hughes; Jack Greenblatt; Shelley L. Berger
ABSTRACT The SAGA complex is a multisubunit protein complex involved in transcriptional regulation in Saccharomyces cerevisiae. SAGA combines proteins involved in interactions with DNA-bound activators and TATA-binding protein (TBP), as well as enzymes for histone acetylation (Gcn5) and histone deubiquitylation (Ubp8). We recently showed that H2B ubiquitylation and Ubp8-mediated deubiquitylation are both required for transcriptional activation. For this study, we investigated the interaction of Ubp8 with SAGA. Using mutagenesis, we identified a putative zinc (Zn) binding domain within Ubp8 as being critical for the association with SAGA. The Zn binding domain is required for H2B deubiquitylation and for growth on media requiring Ubp8s function in gene activation. Furthermore, we identified an 11-kDa subunit of SAGA, Sgf11, and showed that it is required for the Ubp8 association with SAGA and for H2B deubiquitylation. Different approaches indicated that the functions of Ubp8 and Sgf11 are related and separable from those of other components of SAGA. In particular, the profiles of Ubp8 and Sgf11 deletions were remarkably similar in microarray analyses and synthetic genetic interactions and were distinct from those of the Spt3 and Spt8 subunits of SAGA, which are involved in TBP regulation. These data indicate that Ubp8 and Sgf11 likely represent a new functional module within SAGA that is involved in gene regulation through H2B deubiquitylation.
Genes & Development | 2003
Karl W. Henry; Anastasia Wyce; Wan Sheng Lo; Laura J. Duggan; N. C. Tolga Emre; Cheng-Fu Kao; Lorraine Pillus; Ali Shilatifard; Mary Ann Osley; Shelley L. Berger
Journal of Biological Chemistry | 2002
Westley J. Friesen; Anastasia Wyce; Sergey Paushkin; Linda Abel; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Molecular Cell | 2007
Anastasia Wyce; Tiaojiang Xiao; Kelly A. Whelan; Christine Kosman; Wendy Walter; Dirk Eick; Timothy R. Hughes; Nevan J. Krogan; Shelley L. Berger
Molecular Cell | 2005
N. C. Tolga Emre; Kristin Ingvarsdottir; Anastasia Wyce; Adam Wood; Nevan J. Krogan; Karl W. Henry; Keqin Li; Ronen Marmorstein; Jack Greenblatt; Ali Shilatifard; Shelley L. Berger
Structure | 2006
Vinod Nayak; Kehao Zhao; Anastasia Wyce; Marc F. Schwartz; Wan-Sheng Lo; Shelley L. Berger; Ronen Marmorstein
Novartis Foundation symposium | 2004
Anastasia Wyce; Karl W. Henry; Shelley L. Berger